Brown & Brown slides as investors refocus on organic-growth pressure and post-deal integration risks

Brown & Brown, Inc. (BRO) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to renewed concerns that Brown & Brown’s underlying organic growth could stay pressured amid heightened competition for insurance talent, alongside lingering uncertainty around integration execution after recent large acquisitions. This could also be a continuation of post-earnings repositioning as investors digest softer-than-expected elements in the latest quarter.

Details:

Several recent analyst actions have emphasized competition for producers and “talent” as a potential drag on organic growth over the next few years, which can weigh on sentiment even without new company-specific headlines.

In the most recent earnings cycle, investors focused on the gap between acquisition-driven revenue growth and weaker core/organic trends, a setup that can lead to multiple compression for brokers priced for steady mid-single-digit organic growth.

Management commentary has highlighted integration work tied to the Accession transaction and synergy capture expectations; any perceived execution risk can pressure shares on down days.

This move may also reflect broader rotation away from insurance brokers if the market is pricing in a more competitive pricing environment and/or lower forward investment income versus last year.

Sources:

Investing.com, StreetInsider, TipRanks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BRO Hedge Fund Activity

We have seen 390 institutional investors add shares of $BRO stock to their portfolio, and 592 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL INTERNATIONAL INVESTORS added 4,663,165 shares (+inf%) to their portfolio in Q4 2025, for an estimated $371,654,250
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,628,321 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $368,877,183
SELECT EQUITY GROUP, L.P. added 3,358,403 shares (+55.3%) to their portfolio in Q4 2025, for an estimated $267,664,719
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. added 2,589,048 shares (+132.8%) to their portfolio in Q4 2025, for an estimated $206,347,125
NORGES BANK added 2,572,629 shares (+65.8%) to their portfolio in Q4 2025, for an estimated $205,038,531
BOSTON PARTNERS removed 1,570,698 shares (-98.9%) from their portfolio in Q4 2025, for an estimated $125,184,630
ROYAL BANK OF CANADA removed 1,491,211 shares (-30.5%) from their portfolio in Q4 2025, for an estimated $118,849,516

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BRO Congressional Stock Trading

Members of Congress have traded $BRO stock 17 times in the past 6 months. Of those trades, 11 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $BRO stock by members of Congress over the last 6 months:

REPRESENTATIVE BYRON DONALDS has traded it 5 times. They made 3 purchases worth up to $45,000 on 10/24, 10/09 and 2 sales worth up to $30,000 on 02/10.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 6 times. They made 6 purchases worth up to $90,000 on 02/06, 12/12, 12/05, 11/20, 10/31, 10/29 and 0 sales.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/18 and 1 sale worth up to $15,000 on 01/09.
REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 12/11.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BRO Analyst Ratings

Wall Street analysts have issued reports on $BRO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 01/15/2026

To track analyst ratings and price targets for $BRO, check out Quiver Quantitative's $BRO forecast page.

$BRO Price Targets

Multiple analysts have issued price targets for $BRO recently. We have seen 13 analysts offer price targets for $BRO in the last 6 months, with a median target of $81.0.

Here are some recent targets:

Rowland Mayor from RBC Capital set a target price of $76.0 on 03/17/2026
Alex Scott from Barclays set a target price of $80.0 on 03/11/2026
Yaron Kinar from Mizuho set a target price of $85.0 on 02/27/2026
Elyse Greenspan from Wells Fargo set a target price of $78.0 on 02/13/2026
Michael Zaremski from BMO Capital set a target price of $81.0 on 01/29/2026
Weston Bloomer from UBS set a target price of $81.0 on 01/29/2026
Bob Huang from Morgan Stanley set a target price of $78.0 on 01/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.